{"id":58015,"date":"2024-02-27T18:12:30","date_gmt":"2024-02-27T18:12:30","guid":{"rendered":"https:\/\/medsname.com\/etibo\/"},"modified":"2026-04-30T10:17:00","modified_gmt":"2026-04-30T10:17:00","slug":"etibo","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/etibo\/","title":{"rendered":"Etibo"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:18px 0;border-radius:4px;\">\n<p style=\"margin:0 0 8px 0;\"><strong>\ud83d\udca1 Gyors v\u00e1lasz<\/strong><\/p>\n<p style=\"margin:0;\"><strong>Etibo<\/strong> is <strong>lapatinib 250 mg<\/strong>, amely <strong>kett\u0151s HER2\/EGFR tirozin-kin\u00e1z g\u00e1tl\u00f3<\/strong> halad\u00f3 vagy \u00e1tt\u00e9tes <strong>HER2-pozit\u00edv mellr\u00e1k<\/strong>. hoz. Naponta egyszer alkalmazott or\u00e1lis ter\u00e1pia, \u00e1ltal\u00e1ban kapecitabin vagy m\u00e1s kezel\u00e9si rendszer kombin\u00e1ci\u00f3j\u00e1ban, leggyakrabban trastuzumab (Herceptin) kezel\u00e9s sikertelens\u00e9ge ut\u00e1n. Jelent\u0151s mell\u00e9khat\u00e1sok k\u00f6z\u00e9 tartozik a hasmen\u00e9s, ki\u00fct\u00e9sek \u00e9s cardiotoxicit\u00e1s; szoros onkol\u00f3giai fel\u00fcgyelet \u00e9s EKG-monitoroz\u00e1s sz\u00fcks\u00e9ges.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Mit kapsz a MedsBase-n\u00e1l:<\/strong> WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 \u00b7 Diszkr\u00e9t csomagol\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 1.400+ hiteles\u00edtett <a href=\"https:\/\/medsbase.com\/hu\/reviews\/\">v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Minden rendel\u00e9st fedez a <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\"><strong>\u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n<h3>Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n<p>Generikus gy\u00f3gyszereink WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmaznak, \u00e9s diszkr\u00e9t, egyszer\u0171 csomagol\u00e1sban sz\u00e1ll\u00edtjuk \u0151ket vil\u00e1gszerte \u2014 a csomagon nem szerepel a gy\u00f3gyszer neve. A k\u00e1rty\u00e1s fizet\u00e9sek egy szab\u00e1lyozott feldolgoz\u00f3n kereszt\u00fcl t\u00f6rt\u00e9nnek (a sz\u00e1mlale\u00edr\u00e1sok egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3t tartalmaznak \u2014 soha nem \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszer neve). Kriptovalut\u00e1t \u00e9s SEPA banki \u00e1tutal\u00e1st is elfogadunk. Minden rendel\u00e9st a Reshipment Assurance Policy biztos\u00edt\u00e9k fedez.<\/p>\n<div style=\"background:#f4f8fb;border-left:4px solid #2c7cb0;padding:14px 20px;margin:16px 0;border-radius:4px;font-size:0.95em;\">\n<strong>\ud83d\udd12 Mi\u00e9rt \u00e9rdemes a MedsBase-t\u0151l rendelni:<\/strong> Hiteles gy\u00e1rt\u00f3i ell\u00e1t\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 Biztons\u00e1gos fizet\u00e9s (bankk\u00e1rtya, kriptovaluta) \u00b7 1400+ \u00fcgyf\u00e9l \u00e1ltal 4.9\u2605-os \u00e9rt\u00e9kel\u00e9s\n<\/div>\n<h2><strong>Mi az Etibo?<\/strong><\/h2>\n<p>Az Etibo egy m\u00e1rk\u00e1s generikus v\u00e1ltozata a <strong>lapatinib<\/strong> 250 mg, egy kis molekulat\u00f6meg\u0171 tirozin-kin\u00e1z g\u00e1tl\u00f3, amely c\u00e9lba veszi <strong>HER2 (ErbB2)<\/strong> \u00e9s <strong>EGFR (ErbB1)<\/strong>. A lapatinib blokkolja ezen receptorok lefel\u00e9 ir\u00e1nyul\u00f3 intracellul\u00e1ris jel\u00e1tvitel\u00e9t, meg\u00e1ll\u00edtva a HER2-pozit\u00edv r\u00e1ksejtek prolifer\u00e1ci\u00f3j\u00e1t. Natco Pharma gy\u00e1rtja.<\/p>\n<p><strong>Kritikus fontoss\u00e1g\u00fa:<\/strong> A lapatinib onkol\u00f3giai gy\u00f3gyszer, amely csak szakorvosi fel\u00fcgyelet mellett haszn\u00e1lhat\u00f3. Nem \u00e1ltal\u00e1nos n\u0151eg\u00e9szs\u00e9g\u00fcgyi term\u00e9k. Szigor\u00faan onkol\u00f3gusi protokoll szerint alkalmazand\u00f3 \u2014 jellemz\u0151en trastuzumab-rezisztencia kialakul\u00e1sa ut\u00e1n.<\/p>\n<h2><strong>Klinikai alkalmaz\u00e1s<\/strong><\/h2>\n<ul>\n<li><strong>Halad\u00f3\/metasztatikus HER2+ eml\u0151r\u00e1k<\/strong>: napi 1250 mg (5 tabletta) + kapecitabin \u2014 trastuzumab-ter\u00e1pia kudarca ut\u00e1n.<\/li>\n<li><strong>HER2+ eml\u0151r\u00e1k letrozollal<\/strong> postmenopaus\u00e1lis n\u0151kben ER+\/HER2+ metastatikus betegs\u00e9gben.<\/li>\n<li><strong>Nem javasolt<\/strong> adjuv\u00e1ns (korai st\u00e1dium\u00fa gy\u00f3gy\u00edt\u00f3) ter\u00e1pi\u00e1ra \u2014 a trastuzumab \u00b1 pertuzumab tov\u00e1bbra is a standard kezel\u00e9s.<\/li>\n<\/ul>\n<h2><strong>Hogyan alkalmazand\u00f3<\/strong><\/h2>\n<ol>\n<li>Vegyen be <strong>1250 mg (5 tabletta) naponta egyszer<\/strong>, <strong>legal\u00e1bb 1 \u00f3r\u00e1val \u00e9tkez\u00e9s el\u0151tt vagy ut\u00e1n<\/strong>. Az \u00e9tkez\u00e9s jelent\u0151sen n\u00f6veli a felsz\u00edv\u00f3d\u00e1st \u00e9s m\u00f3dos\u00edtja a d\u00f3zisparam\u00e9tereket; a k\u00f6vetkezetess\u00e9g fontos.<\/li>\n<li>Tipikus kombin\u00e1ci\u00f3s gy\u00f3gyszer: kapecitabin 2000 mg\/m\u00b2\/nap a 21 napos ciklus 1\u201314. napj\u00e1n.<\/li>\n<li>Alapvizsg\u00e1lat \u00e9s LVEF monitoroz\u00e1s 3 havonta (kardiotoxicit\u00e1si kock\u00e1zat).<\/li>\n<li>Kezelje proakt\u00edvan a hasmen\u00e9st \u2014 gyakran 1\u20133. fokozat\u00fa, gyakori az els\u0151 kezel\u00e9si ciklusban. Loperamid, hidrat\u00e1l\u00e1s, adagcs\u00f6kkent\u00e9s sz\u00fcks\u00e9g szerint.<\/li>\n<li>Ker\u00fclje a grapefruitot, a sevillei narancsot \u00e9s a CYP3A4 g\u00e1tl\u00f3kat\/induktorokat.<\/li>\n<\/ol>\n<h2><strong>Mell\u00e9khat\u00e1sok<\/strong><\/h2>\n<p><strong>Nagyon gyakori:<\/strong> hasmen\u00e9s (60\u201380%), ki\u00fct\u00e9s (40\u201360%), h\u00e1nyinger, h\u00e1ny\u00e1s, f\u00e1radts\u00e1g, k\u00e9z-l\u00e1b szindr\u00f3ma, palmar-plantaris erythrodysaesthesia (kapecitabin kombin\u00e1ci\u00f3val).<\/p>\n<p><strong>Komoly mell\u00e9khat\u00e1sok:<\/strong> <strong>m\u00e1jm\u00e9rgez\u00e9s<\/strong> (monitorozza a m\u00e1jfunkci\u00f3t), <strong>kardiotoxicit\u00e1s \/ cs\u00f6kkent bal kamrai ejekci\u00f3s frakci\u00f3<\/strong> (5\u20136%), QT-intervallum meghosszabbod\u00e1s, interstiti\u00e1lis t\u00fcd\u0151betegs\u00e9g (ritka, de s\u00falyos).<\/p>\n<p><strong>S\u00falyos:<\/strong> s\u00falyos m\u00e1jk\u00e1rosod\u00e1s, sz\u00edvel\u00e9gtelens\u00e9g, s\u00falyos b\u0151rreakci\u00f3k (Stevens-Johnson szindr\u00f3ma), t\u00fcd\u0151toxicit\u00e1s.<\/p>\n<h2><strong>Kik ne vegy\u00e9k be az Etib\u00f3t<\/strong><\/h2>\n<ul>\n<li>HER2-negat\u00edv eml\u0151r\u00e1k (hat\u00e1stalan)<\/li>\n<li>S\u00falyos m\u00e1jel\u00e9gtelens\u00e9g<\/li>\n<li>Szimptomatikus sz\u00edvel\u00e9gtelens\u00e9g vagy s\u00falyos sz\u00edvfunkci\u00f3-roml\u00e1s<\/li>\n<li>Terhess\u00e9g \u2013 teratog\u00e9n hat\u00e1s<\/li>\n<li>Egyidej\u0171 er\u0151s CYP3A4 g\u00e1tl\u00f3k vagy induk\u00e1l\u00f3k d\u00f3zisbe\u00e1ll\u00edt\u00e1s n\u00e9lk\u00fcl<\/li>\n<\/ul>\n<h2><strong>Gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sok<\/strong><\/h2>\n<ul>\n<li><strong>Er\u0151s CYP3A4 g\u00e1tl\u00f3k<\/strong> (ketokonazol, ritonavir, klaritromicin, grapefruit): jelent\u0151sen n\u00f6veli a lapatinib szintj\u00e9t.<\/li>\n<li><strong>Er\u0151s CYP3A4 induk\u00e1l\u00f3k<\/strong> (rifampicin, karbamazepin, fenitoin, orb\u00e1ncf\u0171): cs\u00f6kkenti a lapatinib szintj\u00e9t \u00e9s hat\u00e9konys\u00e1g\u00e1t.<\/li>\n<li><strong>PPI-k, H2-blokkol\u00f3k<\/strong>: cs\u00f6kkenti a felsz\u00edv\u00f3d\u00e1st \u2013 ker\u00fclje vagy \u00f3r\u00e1kkal el\u0151zze meg az adagol\u00e1st.<\/li>\n<li><strong>Varfarin, digoxin<\/strong>: n\u00f6velheti a szintj\u00fcket.<\/li>\n<\/ul>\n<h2><strong>T\u00e1rol\u00e1s<\/strong><\/h2>\n<p>Szobah\u0151m\u00e9rs\u00e9kleten (15\u201330 \u00b0C) t\u00e1roland\u00f3, nedvess\u00e9gt\u0151l v\u00e9dve. Az eredeti csomagol\u00e1sban tartand\u00f3. Gyermekek sz\u00e1m\u00e1ra el\u00e9rhetetlen helyen tartand\u00f3.<\/p>\n<h2 id=\"faqs\">Gyakran Ism\u00e9telt K\u00e9rd\u00e9sek<\/h2>\n<h3 class=\"wp-block-heading\">Mikor alkalmazz\u00e1k a lapatinibot?<\/h3>\n<p>Halad\u00f3\/metasztatikus HER2-pozit\u00edv eml\u0151r\u00e1k, \u00e1ltal\u00e1ban trastuzumab (Herceptin) rezisztencia ut\u00e1n. Nem haszn\u00e1lhat\u00f3 korai st\u00e1dium\u00fa gy\u00f3gy\u00edt\u00f3 kezel\u00e9sre.<\/p>\n<h3 class=\"wp-block-heading\">Mi\u00e9rt kell \u00fcres gyomorral bevenni?<\/h3>\n<p>Az \u00e9tel 4\u20135-sz\u00f6r\u00f6s\u00e9re n\u00f6veli a lapatinib felsz\u00edv\u00f3d\u00e1s\u00e1t, ami kisz\u00e1m\u00edthatatlann\u00e1 teszi az adagol\u00e1st. A szabv\u00e1nyos elj\u00e1r\u00e1s a k\u00f6vetkezetes b\u00f6jt \u2013 1 \u00f3r\u00e1val \u00e9tel el\u0151tt vagy ut\u00e1n \u2013 minden nap ugyanabban az id\u0151pontban.<\/p>\n<h3 class=\"wp-block-heading\">Mennyire s\u00falyos a hasmen\u00e9s?<\/h3>\n<p>Gyakori, gyakran 1\u20132. fokozat\u00fa; kezelhet\u0151 loperamiddal \u00e9s folyad\u00e9kp\u00f3tl\u00e1ssal. 3. fokozat\u00fa vagy s\u00falyosabb hasmen\u00e9s eset\u00e9n sz\u00fcks\u00e9g lehet a kezel\u00e9s ideiglenes felf\u00fcggeszt\u00e9s\u00e9re \u00e9s az adag cs\u00f6kkent\u00e9s\u00e9re. Jelentse kor\u00e1n.<\/p>\n<h3 class=\"wp-block-heading\">K\u00e1ros\u00edtja-e a lapatinib a sz\u00edvemet?<\/h3>\n<p>A betegek kb. 5\u20136%-\u00e1ban fordul el\u0151 t\u00fcnetmentes bal kamrai ejekci\u00f3s frakci\u00f3 (LVEF) cs\u00f6kken\u00e9s. Alapvizsg\u00e1latk\u00e9nt \u00e9s 3 havont EKG + echokardiogr\u00e1fia sz\u00fcks\u00e9ges. \u00c1ltal\u00e1ban reverzibilis az adag m\u00f3dos\u00edt\u00e1s\u00e1val vagy a kezel\u00e9s sz\u00fcneteltet\u00e9s\u00e9vel.<\/p>\n<h3 class=\"wp-block-heading\">Vehetem a lapatinibot trastuzumabbal egy\u00fctt?<\/h3>\n<p>A lapatinib \u00e9s trastuzumab kombin\u00e1ci\u00f3j\u00e1t specifikus protokollokban alkalmazz\u00e1k. Nem rutinbev\u00e1g\u00f3, onkol\u00f3gus fel\u00fcgyelete n\u00e9lk\u00fcl nem javasolt.<\/p>\n<h3 class=\"wp-block-heading\">Mi a helyzet a term\u00e9kenys\u00e9ggel?<\/h3>\n<p>A kezel\u00e9s alatt \u00e9s azt k\u00f6vet\u0151 1 h\u00e9tig hat\u00e9kony fogamz\u00e1sg\u00e1tl\u00e1s sz\u00fcks\u00e9ges (teratog\u00e9n hat\u00e1s). F\u00e9rfiaknak a kezel\u00e9s alatt \u00e9s azt k\u00f6vet\u0151 3 h\u00f3napig kell hat\u00e9kony fogamz\u00e1sg\u00e1tl\u00e1st alkalmazniuk.<\/p>\n<h3 class=\"wp-block-heading\">Mi\u00e9rt tartozik ez a N\u0151i eg\u00e9szs\u00e9g kateg\u00f3ri\u00e1ba?<\/h3>\n<p>A HER2-pozit\u00edv mellr\u00e1k ar\u00e1nytalanul nagyobb m\u00e9rt\u00e9kben \u00e9rinti a n\u0151ket (b\u00e1r ritk\u00e1n f\u00e9rfiak is kaphatnak HER2-pozit\u00edv mellr\u00e1kot). A kategoriz\u00e1l\u00e1s a popul\u00e1ci\u00f3t t\u00fckr\u00f6zi, nem szigor\u00fa klinikai csoportos\u00edt\u00e1st.<\/p>\n<h3 class=\"wp-block-heading\">A lapatinib m\u00e9g mindig els\u0151 vonalbeli kezel\u00e9s?<\/h3>\n<p>A HER2-pozit\u00edv metastatikus betegs\u00e9g m\u00e1sodik vonalbeli kezel\u00e9sek\u00e9nt (trastuzumab ut\u00e1n) \u00e9vekig a lapatinib + kapecitabin volt az aranystandard. Az \u00fajabb lehet\u0151s\u00e9gek (T-DM1\/Kadcyla, T-DXd\/Enhertu, tucatinib) az\u00f3ta nagyban felv\u00e1ltott\u00e1k a fejlett orsz\u00e1gok onkol\u00f3gi\u00e1j\u00e1ban \u2014 a lapatinib tov\u00e1bbra is fontos maradt azokban a r\u00e9gi\u00f3kban, ahol az \u00fajabb szerek nem el\u00e9rhet\u0151k.<\/p>\n<h3 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 n\u0151i eg\u00e9szs\u00e9g\u00fcgyi term\u00e9kek<\/h3>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/tamodex\/\">Tamodex (Tamoxifen 10 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/tamilong\/\">Tamilong (Tamoxifen 20 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/letroheal\/\">Letroheal (Letrozole 2,5 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/duphaston\/\">Duphaston (Didrogeszteron 10 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/deviry\/\">Deviry (Medroksiprogeszteron 10 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/naprosyn\/\">Naprosyn (Naproxen 250 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/candid-v-gel\/\">Candid-V Gel (Clotrimazole)<\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 20px;margin:16px 0;border-radius:4px;font-size:0.9em;\">\n<p style=\"margin:0;\"><strong>\u2695\ufe0f Orvosi nyilatkozat:<\/strong> Az inform\u00e1ci\u00f3 t\u00e1j\u00e9koztat\u00f3 jelleg\u0171, \u00e9s nem helyettes\u00edti az orvosi tan\u00e1csot. Minden gy\u00f3gyszer szed\u00e9se, abbahagy\u00e1sa vagy m\u00f3dos\u00edt\u00e1sa el\u0151tt, k\u00fcl\u00f6n\u00f6sen a r\u00e1kter\u00e1pia, hormon\u00e1lis kezel\u00e9sek \u00e9s v\u00e9nyk\u00f6teles term\u00e9kek eset\u00e9ben, konzult\u00e1ljon klinikai szakemberrel.<\/p>\n<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k<\/h3>\n<p>Tov\u00e1bbi onkol\u00f3giai gy\u00f3gyszerek, amelyek e term\u00e9k mellett el\u00e9rhet\u0151k:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/verpin\/\">Verpin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/triohale-rotacaps\/\">Triohale Rotacaps<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/inderal\/\">Inderal<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/hydrocl\/\">Hydrocl<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/ezedoc\/\">Ezedoc<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 R\u00e1kos sejteket c\u00e9loz<br \/>\n\u2705 G\u00e1tolja a daganat n\u00f6veked\u00e9s\u00e9t<br \/>\n\u2705 Mellr\u00e1k kezel\u00e9s\u00e9re<br \/>\n\u2705 Blokkolja a HER2 receptorokat<br \/>\n\u2705 T\u00fal\u00e9l\u00e9si ar\u00e1nyok jav\u00edt\u00e1s\u00e1ra<\/p>\n<p>Az Etibo Lapatinibot tartalmaz.<\/p>","protected":false},"featured_media":58016,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3595,3141,3223,3502],"product_tag":[4402,4403],"class_list":{"0":"post-58015","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-cancer-medication","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","9":"product_cat-womens-health","10":"product_tag-etibo","11":"product_tag-lapatinib","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product\/58015","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/comments?post=58015"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media\/58016"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media?parent=58015"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_brand?post=58015"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat?post=58015"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_tag?post=58015"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}